Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...

WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift ® System, a proven, minimally ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Sponsored content: Enlarged prostate affects ...

MINNEAPOLIS (WCCO)-- Experts say as men age, their prostate gland can become enlarged and affects how often they have to go to the bathroom, among other disruptions. Now, there's a newer in-office ...

New Delhi, Nov 09, 2022: Teleflex has announced the commercial launch of the UroLift System in India for treating benign prostatic hyperplasia (BPH), or enlarged prostate. The UroLift System is a ...

GRESHAM, Ore. — A new FDA-approved outpatient procedure for men 55 and over who suffer from frequent urination promises immediate relief from an enlarge prostate without painful surgery or a long ...

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ ...

As the population ages, the prevalence of Benign Prostatic Hyperplasia (BPH)—commonly known as an enlarged prostate—has increased significantly. Over 50% of men over 60 and 80% of those over 70 ...

Urolift is a minimally invasive procedure to help treat an enlarged prostate, known as benign prostatic hyperplasia (BPH). Medicare will typically cover Urolift procedures when a doctor deems them ...